Gallbladder cancer epidemiology, treatment and survival in Southern Finland - a population-based study

Scand J Gastroenterol. 2021 Aug;56(8):929-939. doi: 10.1080/00365521.2021.1915373. Epub 2021 Jul 5.

Abstract

Introduction: Gallbladder cancer (GBC) is a rare malignancy in Western population with poor prognosis. This study aimed to investigate the trends in GBC incidence, treatment pattern, and survival in Finland.

Methods: Patients diagnosed with primary GBC in a geographically defined area (Southern Finland Regional Cancer Center) during 2006-2017 were identified.

Results: Final cohort included 270 patients with GBC. The incidence was 1.32/100,000 persons, and it decreased 6.8 cases per million personyears during the study period. One hundred fifty-one (56%) patients were diagnosed at Stage IV. Fifty-one patients (19%) underwent curative-intent resection with 96% R0-resection rate. The median overall survival was 7.1 months and 5-year overall survival 11.6% for all patients, and 67.7 months and 56.8% after curative-intent resection, respectively. No improvement was noted over time in overall survival in patients with GBC, or in subgroups of different stages of GBC.

Conclusions: The incidence of GBC is slightly decreasing in Southern Finland, but survival has not improved over time.

Keywords: Incidence; biliary tract cancer; neoplasm.

MeSH terms

  • Carcinoma in Situ*
  • Finland / epidemiology
  • Gallbladder Neoplasms* / epidemiology
  • Gallbladder Neoplasms* / pathology
  • Gallbladder Neoplasms* / therapy
  • Humans
  • Incidence
  • Neoplasm Staging
  • Retrospective Studies
  • Survival Rate